Masayuki Iwata

582 total citations
32 papers, 470 citations indexed

About

Masayuki Iwata is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, Masayuki Iwata has authored 32 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Pharmacology and 8 papers in Immunology. Recurrent topics in Masayuki Iwata's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Veterinary medicine and infectious diseases (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Masayuki Iwata is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Veterinary medicine and infectious diseases (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Masayuki Iwata collaborates with scholars based in Japan, United States and Germany. Masayuki Iwata's co-authors include Takaichi Shimozato, N Tamura, Takashi Morishita, Hiroshi Kawada, Hiroshi Tokiwa, E Tsubura, S. Sugawara, Hiroaki Yanagisawa, Hideo Nakao and Junya Ide and has published in prestigious journals such as Blood, Applied and Environmental Microbiology and Biochemical and Biophysical Research Communications.

In The Last Decade

Masayuki Iwata

31 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masayuki Iwata Japan 13 144 117 97 56 53 32 470
Hiroshi Shionoya Japan 13 201 1.4× 229 2.0× 89 0.9× 24 0.4× 23 0.4× 34 719
W. Roszkowski Poland 14 167 1.2× 209 1.8× 46 0.5× 27 0.5× 52 1.0× 60 600
Matthew Stephens Canada 13 112 0.8× 230 2.0× 30 0.3× 81 1.4× 40 0.8× 33 616
Yoshihiro Yokota Japan 14 56 0.4× 149 1.3× 82 0.8× 155 2.8× 33 0.6× 25 553
T Nishimura Japan 14 125 0.9× 138 1.2× 46 0.5× 54 1.0× 13 0.2× 47 579
Cathleen Collins-Lech United States 14 205 1.4× 249 2.1× 46 0.5× 25 0.4× 19 0.4× 22 667
Tomasz Maślanka Poland 13 191 1.3× 84 0.7× 108 1.1× 44 0.8× 15 0.3× 63 578
Catlyn Blanchard United States 11 100 0.7× 284 2.4× 35 0.4× 43 0.8× 23 0.4× 15 556
A. Acquafredda Italy 14 171 1.2× 194 1.7× 26 0.3× 28 0.5× 13 0.2× 36 725
Fernanda de Assis Araújo Brazil 15 120 0.8× 175 1.5× 48 0.5× 80 1.4× 19 0.4× 41 664

Countries citing papers authored by Masayuki Iwata

Since Specialization
Citations

This map shows the geographic impact of Masayuki Iwata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Iwata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Iwata more than expected).

Fields of papers citing papers by Masayuki Iwata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Iwata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Iwata. The network helps show where Masayuki Iwata may publish in the future.

Co-authorship network of co-authors of Masayuki Iwata

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Iwata. A scholar is included among the top collaborators of Masayuki Iwata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Iwata. Masayuki Iwata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koga, Tetsufumi, et al.. (2003). Essential role of magnesium ion in water for colonization of Helicobacter pylori in 2-week-old miniature pigs. Microbiological Research. 158(1). 69–75. 4 indexed citations
2.
Koga, Tetsufumi, et al.. (2002). Experimental Helicobacter pylori gastric infection in miniature pigs. Journal of Medical Microbiology. 51(3). 238–246. 10 indexed citations
3.
Koga, Tetsufumi, et al.. (2002). Contribution of ferrous iron to maintenance of the gastric colonization of Helicobacter pylori in miniature pigs. Microbiological Research. 157(4). 323–330. 5 indexed citations
4.
Ohya, Satoshi, Yukio Utsui, Hisanori Domon, et al.. (1997). In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem. Antimicrobial Agents and Chemotherapy. 41(12). 2652–2663. 22 indexed citations
5.
Nunoi, Hiroyuki, et al.. (1995). AG dinucleotide insertion in a patient with chronic granulomatous disease lacking cytosolic 67-kD protein. Blood. 86(1). 329–333. 21 indexed citations
6.
Iwata, Masayuki, Hiroyuki Nunoi, Hajime Yamazaki, et al.. (1994). Homologous Dinucleotide (GT or TG) Deletion in Japanese Patients with Chronic Granulomatous Disease with p47-Phox Deficiency. Biochemical and Biophysical Research Communications. 199(3). 1372–1377. 31 indexed citations
7.
Shimozato, Takaichi, Masayuki Iwata, & N Tamura. (1990). Suppression of tumor necrosis factor alpha production by a human immunoglobulin preparation for intravenous use. Infection and Immunity. 58(5). 1384–1390. 44 indexed citations
9.
Ohya, Satoshi, et al.. (1988). ANTIBACTERIAL ACTIVITY OF CS-807, A NEW ORALLY ACTIVE CEPHALOSPORIN:I. COMPARISON OF IN VITRO ACTIVITY OF CS-807. 36(1). 104–145. 2 indexed citations
10.
Yasuda, Hiroshi, et al.. (1988). Antibacterial activity of CS-807, a new orally active cephalosporin III: In vivo evaluations. Chemotherapy. 36. 159–172. 1 indexed citations
11.
Utsui, Yukio, et al.. (1988). ANTIBACTERIAL ACTIVITIES OF CS-807, A NEW ORALLY ACTIVE CEPHALOSPORIN:II. ANTIBACTERIAL MECHANISM. 36(1). 146–158. 2 indexed citations
12.
Utsui, Yukio, et al.. (1988). Antibacterial activity of CS-807, A new orally active cephalosporin. Chemotherapy. 36. 104–145. 2 indexed citations
13.
Iwata, Masayuki. (1988). Characterization of a pAMβ1 deletion derivative isolated from Lactobacillus casei after conjugation. Biochimie. 70(4). 553–558. 15 indexed citations
14.
Iwata, Masayuki, Takaichi Shimozato, Hiroshi Tokiwa, & E Tsubura. (1987). Antipyretic activity of a human immunoglobulin preparation for intravenous use in an experimental model of fever in rabbits. Infection and Immunity. 55(3). 547–554. 36 indexed citations
15.
Ugawa, Yoshikazu, Nobuo Kohara, Hideto Hirasawa, et al.. (1987). Myoclonus in Alzheimer's disease. Journal of Neurology. 235(2). 90–94. 26 indexed citations
16.
Iwata, Masayuki, Hiroshi Tokiwa, & Tyoku Matuhasi. (1983). Detection and Characterization of Polymers in Cephalothin by Passive Cutaneous Anaphylaxis in Mice. International Archives of Allergy and Immunology. 70(2). 132–137. 13 indexed citations
17.
Ishikura, Nariyuki, et al.. (1983). The influence of some inhibitors on the formation of caffeic acid in cultures ofPerilla cell suspensions. Journal of Plant Research. 96(2). 111–120. 3 indexed citations
18.
Iwata, Masayuki, et al.. (1982). Antigenicity of Beta-Lactam Antibiotic Preparations: Production of IgE Antibodies to Beta-Lactam Antibiotic and Their Cross-Reaction Within the Antibiotic Group. International Archives of Allergy and Immunology. 68(1). 35–40. 2 indexed citations
19.
Iwata, Masayuki & Tyoku Matuhasi. (1978). Immunological studies on CS-1170, a new semisynthetic cephamycin antibiotic.. PubMed. 48(5). 401–10. 2 indexed citations
20.
Iwata, Masayuki, et al.. (1974). IMMUNOLOGICAL STUDIES ON PIVAMPICILLIN. 22(4). 388–396. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026